<DOC>
	<DOCNO>NCT01936025</DOCNO>
	<brief_summary>The study randomize , double-blind , placebo-controlled , double dummy eight-way cross-over design . Males T2DM stable metformin monotherapy screen participation study . Eligible subject randomize receive DXM 30 mg , DXM 60 mg , DXM 90 mg alone combination sitagliptin 100 mg , sitagliptin 100 mg alone , placebo ( DXM sitagliptin ) total eight treatment day . An OGTT start 1 hour study drug administration blood glucose measure next 4 hour . There 3 14-day washout period dos .</brief_summary>
	<brief_title>A Study Investigate Glucose Lowering Effects Dextromethorphan Alone Combination With Sitagliptin Subjects With Type 2 Diabetes Mellitus ( T2DM ) After Oral Glucose Tolerance Test</brief_title>
	<detailed_description>This study perform determine optimal dose DXM , compare placebo , decrease glucose excursion follow OGTT . Doses 30 mg , 60 mg 90 mg DXM chosen . Since DXM 60 mg effective previous study increase insulin secretion , dose kept . A low dose ( 30 mg ) give see whether effect insulin secretion present also low dos translate BG lower action . A high dose ( 90 mg ) add see whether way effect glucose excursion reduction occur follow OGTT , ( like previously demonstrate 270 mg DXM ) relate increase insulin secretion .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Dextromethorphan</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>1 . Signed date write informed consent obtain studyrelated activity 2 . Male subject diagnosis type 2 diabetes mellitus accord ADA criterion least 4 month prior screen 3 . Medical history without major pathology ( exception type 2 diabetes ) 4 . On stable regimen metformin monotherapy least 3 month 5 . Aged 45 70 year age , inclusive 6 . Body mass index ( BMI ) 25 35kg/m2 , inclusive 1 . Subjects type 1 diabetes , MODY secondary form diabetes due pancreatitis 2 . History pancreatitis 3 . Current previous treatment insulin therapy 4 . Treatment hypoglycemic medication metformin within three month prior screen 5 . Mean QTc &gt; 450 msec</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Diabetes mellitus</keyword>
</DOC>